SCHEMBL5669922

SCHEMBL5669922

CCCCCNC(=O)CN(C(=O)c1ccc2nc(N)ccc2c1)c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 2/20 0.49
▸ HDAC6 Q9UBN7 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ PLAU P00749 3/20 0.41
▸ ADRB2 P07550 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ NAAA Q02083 1/20 0.39
▸ F2 P00734 1/20 0.39
▸ NPC1 O15118 1/20 0.38
▸ JAK2 O60674 1/20 0.38
▸ RAB9A P51151 1/20 0.38
▸ PAX8 Q06710 1/20 0.38
▸ ALOX15 P16050 3/20 0.38
▸ ASAH1 Q13510 1/20 0.38
▸ NCF1 P14598 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5669917 0.75 PLAU (0.53) HDAC1PLAU
SCHEMBL13993519 0.74 KDM4E (0.48) ALDH1A1PLAUNAAA
SCHEMBL5669914 0.74 KDM4E (0.48) ALDH1A1PLAUNAAA
SCHEMBL10698289 0.66 EPHX1 (0.49) HDAC1HDAC6NAAA
SCHEMBL14046197 0.66 CYP1A2 (0.57) ALDH1A1MAPTHPGDNPC1RAB9A
SCHEMBL28666105 0.66 NPC1 (0.62) HDAC1HDAC6ALDH1A1HPGDNAAA
SCHEMBL1624886 0.65 F10 (0.54) HDAC1HDAC6ALDH1A1HPGDF2
SCHEMBL11506563 0.65 ADRA2C (0.58) HDAC1HDAC6ALDH1A1MAPTADRB2
SCHEMBL11506841 0.65 ALDH1A1 (0.63) HDAC1HDAC6ALDH1A1MAPTADRB2
SCHEMBL5821101 0.65 NPC1 (0.57) HDAC1HDAC6ALDH1A1HPGDNAAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716137-A1 SUBSTITUTED QUINOLINE COMPOUNDS Pfizer Products Incorporated (US) 2006-11-02 — — EP disclosed
WO-2005080373-A1 SUBSTITUTED QUINOLINE COMPOUNDS PFIZER PRODUCTS INC. (US) 2005-09-01 — — WO disclosed
Send feedback